Xeris Pharmaceuticals | XERS - 销售和管理费用

股票价格

6.05

每天变化

0.10 1.68%

每月一次

14.15%

每年

40.37%

Q2 预测

5.92

金融业

USD

USD 383.53M

现金及等价物

USD 111.04M

USD 13.66M

USD 240.31M

USD 109.57M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.05

股本和储备

USD 13.69M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 220.34M

USD 835.7M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 85.81M

销售和管理费用

USD 42.64M

USD 68.67M

贸易债权人

USD 3.08M

应收帐款人

USD 51.05M

	销售和管理费用	更改		日
Celltrion	KRW 249.98B		16.36B	2025-09
Cspc Pharmaceutical	CNY 1.87B		95.62M	2025-12
Deva Holding AS	TRY 462.26M		48.18M	2023-09
Dianthus Therapeutics	USD 6.57M		1.62M	2025-12
Divis Laboratories Ltd	INR 3.4B		10M	2025-06
Eli Lilly	USD 3.13B		391.3M	2025-12
Kangmei Pharma	CNY 274.41M		15.05M	2025-09
Knight Therapeutics	CAD 35.45M		4.43M	2025-12
Laboratorios Farma	EUR 35.32M		2.75M	2025-06
Malin Corporation	EUR 1.1M		400K	2024-12
Medical Developments International	AUD 2.84M		4.19M	2025-12
Nektar Therapeutics	USD 10.17M		10.17M	2025-12
Neuren Pharmaceuticals	AUD 3.74M		2.5M	2025-12
Organigram Holdings	CAD 7.73M		1.13M	2025-12
Ovoca Bio	EUR 632K		2.33M	2025-06
Pacira	USD 91.87M		70K	2025-12
Perrigo	USD 255.9M		10.2M	2025-12
Pharma Mar	EUR 17.31M		3.6M	2025-12
Qiagen NV	USD 153.88M		10.77M	2025-12
Sartorius	EUR 221.3M		500K	2026-03
Sino Biopharmaceutical	CNY 7.54B		2.23B	2025-06
Supernus Pharmaceuticals	USD 122.39M		57.29M	2025-12
Tilray	USD 24.85M		1.7M	2025-09
Zealand Pharma A/S	91.81M		99.04M	2025-12
Zz Pientze Pharmaceu	CNY 171.91M		343.2M	2025-09